Psychiatry

Quebec-based investigators have highlighted the central role of bridge symptoms in the developmental process leading to long-term anxiety.

Tardive Dyskinesia Assessment Workshop members confirm the AIMS to be a valid measure of TD, but recommends alternative analyses to gauge treatments.

The Childhood Behavior Checklist may help primary care physicians determine if young children are at risk for developing major depressive disorder or anxiety disorders in their teenage and young adult years.

Obsessive compulsive disorder is commonly treated with medicines, psychotherapy, or some combination of the pair. It currently affects about 1% of US adults.

The FDA approved the 2 VMAT-2 drugs for the treatment of tardive dyskinesia in 2017.

The results of a new study point to age-related macular degeneration, diabetic retinopathy, and glaucoma as potential early warning signs that an individual is at risk for developing Alzheimer disease or dementia.

The findings support exploration of LAC as a biomarker and therapeutic target that might help guide individualized treatments in the spirit of precision medicine.

A Denmark retrospective study of 7 million-plus individuals found associations between increased TBI severity and frequency, and suicide risk.

Over time, it has become evident that suicide involves a complex mix of genetics, temperament, circumstances, external support, and access to means.

According to pooled data, 91.8% of the hospitalizations due to firearm injuries in pediatric and adolescent patients were of urban patients, 4.8% were of micropolitan patients, and 3.3% were of rural patients.

From 1999 to 2014, prevalence of opioid use disorder among women giving birth increased 333% nationally, according to a report from the Centers for Disease Control and Prevention.

The novel methylphenidate formulation indicated for evening administration in patients with ADHD aged 6 years and older has shown improvement in the severity of ADHD symptoms in the early morning and throughout the day for patients.

Through Warrior Centric Health, the 25-year US Navy vet has bridged the gap between civilian physicians and the specific-need veterans left behind.

For patients with acute coronary syndrome and depression, taking escitalopram to treat depression resulted in significantly fewer major cardiac events compared to patients given placebo.

The symptoms of tardive dyskinesia and drug-induced parkinsonism can be remarkably similar, but an accurate diagnosis is critical when treatment for one condition may worsen the other.

If done ethically, the genetic database's collaboration with GSK could provide researchers what they really need to improve neurological care: the right patients in the right studies.

Meeting with a peer support worker to complete a personal recovery workbook reduced readmissions over a year for patients with mental health challenges.

A qualitative narrative analysis of 300-plus submitted essays led to answers as to what factors contribute to inclusive environments at work or education institutions.

The combined results of a recent meta-analysis and a new population-based study supports there being a significant association between asthma and ADHD.

The long-acting injectable risperidone (Perseris) will provide an alternative to daily oral medication to improve treatment adherence for patients with schizophrenia.

Researcher from the Indiana University School of Medicine found that at well-child visits 4.4% of fathers reported symptoms of depression compared to 5% of mothers.

A review of literature on depression and anxiety in patients with heart failure reports that 21.5% have depressive symptoms and 19% meet the criteria for a depressive disorder—2 to 3 times higher than rates in the general population.

The statistical algorithm incorporates data including age, depression severity, neuroticism, and cognitive control to decide which patients with depression are most likely to benefit from the antidepressant sertraline.

Newly approved treatments for patients with posttraumatic stress disorder are lacking. Ketamine and cannabinoids could offer hope.

Where does current research focuses its resources, and what may the future of such research involve?